Mesh Resources | GPAC United

top of page

Mesh Resources

GPAC Mesh Resources

Mesh Illness Symptoms

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

Mesh Patient Stories

Mesh News

Mesh Removal Information

Removal of Vaginal Mesh

Removal of Abdominal Mesh

Reporting Adverse Events

Report to Health Canada

Mesh Studies

Dr. Alexander Galvin et al | Mar. 2020
Imaging and Treatment of Complications of Abdominal and Pelvic Mesh Repair

Dr. Galvin et al | 2020

Dr. Willem Cohen Tervaert | Dec. 2018
Autoinflammatory/Autoimmunity Syndrome Induced by Adjuvants (ASIA): A New Flame

Dr. Tervaert | 2018

World Journal of Gastrointestinal Surgery Study | April 2015
Mesh Implants: An Overview of Crucial Mesh Parameters

Lei-Ming Zhu et al | 2015

Regulatory Announcements

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

FDA April 2019 | FDA Orders Mesh Manufacturers to Stop Selling Devices for Tansvaginal Repair of Pelvic Organ Prolapse

FDA Stops Use of TVT

FDA September 2020 | Medical Device Reports for Systemic Symptoms in Women with Breast Implants

FDA January 2016 - FDA Strengthens Requirements for Pelvic Mesh

FDA Strengthens Requirements for Pelvic Mesh

FDA September 2020 | 7 Things You Should Know About Breast Implants

UK MHRA 2014 - 7 Vaginal Mesh Implants: Summary of Benefits and Risks

UK Vaginal Mesh Implants

FDA August 2020 | FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant Associated Lymphoma

NHS England Mesh Working Group Report - Mesh Oversight Report

UK Mesh Oversight Report

FDA August 2020 | FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant Associated Lymphoma

UK MHRA June 2022 | MHRA Future Regulation of Medical Devices in UK

UK Future Device Regulation

FDA August 2020 | FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant Associated Lymphoma

TGA November 2021 | Reclassification of Surgical Mesh Devices

TGA All Mesh Class 3 Devices

Global Regulatory Agencies

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

FDA Food and Drug Administration (United States)

FDA (United States)

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

Health Canada (Canada)

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

MHRA Medicines and Heathcare products Regulatory Agency (United Kingdom)

MHRA (United Kingdom)

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

TGA Therapeutic Goods Administration (Australia)

TGA (Australia)

FDA September 2020 | Labeling Recommendations to Improve Patient Communication

BfArM Federal Institute for Drugs and Medical Devices (Germany)

BfArM (Germany)

bottom of page